Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-05-15 Sale |
2025-05-16 4:31 pm |
Verona Pharma plc | VRNA | Fisher Andrew General Counsel |
80,000 | $8.57 | $685,600 | 2,679,999 (Direct) |
View |
| 2025-04-29 Sale |
2025-05-01 8:59 pm |
Verona Pharma plc | VRNA | Fisher Andrew General Counsel |
26,072 | $8.98 | $234,127 | 780,169 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-05-15 Exercise |
2025-05-16 4:31 pm |
N/A 2034-03-31 |
Verona Pharma plc | VRNA | Fisher Andrew General Counsel |
80,000 | $0 | 2,679,999 (Direct) |
View |
| 2025-05-15 Exercise |
2025-05-16 4:31 pm |
N/A N/A |
Verona Pharma plc | VRNA | Fisher Andrew General Counsel |
80,000 | $2.113 | 2,679,999 (Direct) |
View |
| 2025-04-29 Exercise |
2025-05-01 8:59 pm |
N/A N/A |
Verona Pharma plc | VRNA | Fisher Andrew General Counsel |
86,064 | $0 | 780,169 (Direct) |
View |
| 2025-03-19 Gift |
2025-05-01 8:59 pm |
N/A N/A |
Verona Pharma plc | VRNA | Fisher Andrew General Counsel |
1 | $0 | 780,169 (Direct) |
View |
| 2025-04-29 Option Award |
2025-05-01 8:59 pm |
N/A N/A |
Verona Pharma plc | VRNA | Fisher Andrew General Counsel |
253,120 | $0 | 780,169 (Direct) |
View |
| 2024-10-30 Option Award |
2024-11-01 7:13 pm |
N/A N/A |
Verona Pharma plc | VRNA | Fisher Andrew General Counsel |
300,000 | $0 | 300,000 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-02 4:15 pm |
N/A 2034-03-31 |
Verona Pharma plc | VRNA | Fisher Andrew General Counsel |
2,400,000 | $0 | 2,400,000 (Direct) |
View |